ScholarWorks@Korea University College of Medicine

Diabetes, Obesity and Metabolism

Journal Title

  • Diabetes, Obesity and Metabolism

ISSN

  • E 1463-1326 | P 1462-8902

Publisher

  • Blackwell Publishing Inc.

Listed on(Coverage)

JCR 2000-2019
SJR 2000-2019
CiteScore 2011-2019
SCIE 2010-2021
CC 2016-2021
SCOPUS 2017-2020
MEDLINE 2016-2021
EMBASE 2016-2020

Active

  • Active

    based on the information

    • SCOPUS:2020-10

Country

  • USA

Aime & Scopes

  • Developing World Bioethics provides long needed case studies, teaching materials, news in brief, and legal backgrounds to bioethics scholars and students in developing and developed countries alike. This companion journal to Bioethics also features high-quality peer reviewed original articles. It is edited by well-known bioethicists who are working in developing countries, yet it will also be open to contributions and commentary from developed countries' authors. Developing World Bioethics is the only journal in the field dedicated exclusively to developing countries' bioethics issues. The journal is an essential resource for all those concerned about bioethical issues in the developing world. Members of Ethics Committees in developing countries will highly value a special section dedicated to their work.

Homepage

Article List

1 - 19 out of 19 results.

SCIESCOPUS
Efficacy and safety in tirzepatide-treated Korean adults with type 2 diabetes-A post hoc analysis of SURPASS-AP-combo and SURPASS-3

Lee, Byung Wan; Lee, Chang Beom; Lim, Soo; Kim, Sin Gon; Kim, Nan Hee; Won, Jong Chul; Lee, Woo Je; Kang, Min Ju; Yuh, Ju Young; Du, Li Ying, et al.

ArticleIssue Date2025CitationDiabetes, Obesity and Metabolism, v.27, no.12, pp 7110 - 7122PublisherBlackwell Publishing Inc.
SCIESCOPUS
Sodium-glucose cotransporter 2 inhibitor ameliorates thiazolidinedione-induced fluid retention through vascular leakage reduction in white adipose tissue

Kim, Ji Yoon; Jang, Hye-min; Lee, Hye-Jin; Lee, Ah Hyeon; Kim, Dong-Hoon; Kim, Sin Gon; Kim, Nam Hoon

ArticleIssue Date2025CitationDiabetes, Obesity and MetabolismPublisherBlackwell Publishing Inc.
SCIESCOPUS
Efficacy of phentermine/topiramate extended release in weight management and metabolic profiles: A multicentre study in South Korea

Kim, Kyoung Min; Choi, Jong Han; Han, Byoungduck; Hur, Yang-Im; Son, Jang Won; Nam, Ga Eun; Kang, Jee-Hyun; Cho, Yoon Jeong; Kim, Won Jun; Lim, Soo

ArticleIssue Date2025CitationDiabetes, Obesity and Metabolism, v.27, no.6, pp 3252 - 3261PublisherBlackwell Publishing Inc.
SCIESCOPUS
Association of metabolic dysfunction-associated fatty liver disease with white matter hyperintensity and cognitive decline: A longitudinal cohort study

Jung, Inha; Park, So Young; Lee, Da Young; Cho, Hyun Joo; Lee, Seung Ku; Seo, Ji A.; Kim, Nan Hee; Shin, Chol; Yu, Ji Hee

ArticleIssue Date2025CitationDiabetes, Obesity and Metabolism, v.27, no.4, pp 2271 - 2279PublisherBlackwell Publishing Inc.
SCIESCOPUS
Risk acceleration by gout on major adverse cardiovascular events and all-cause death in patients with diabetes and chronic kidney disease

Lee, Da Young; Moon, Jun Sung; Jung, Inha; Chung, Seung Min; Park, So Young; Yu, Ji Hee; Seo, Ji A.; Han, Kyung-do; Kim, Nan Hee

ArticleIssue Date2025CitationDiabetes, Obesity and Metabolism, v.27, no.3, pp 1554 - 1563PublisherBlackwell Publishing Inc.
SCIESCOPUS
Efficacy and safety of combining empagliflozin in people with type 2 diabetes mellitus uncontrolled with metformin and sitagliptin: A randomised, double-blind, multicentre, therapeutic confirmatory phase 3 clinical trialopen access

Lee, Seunghwan; Han, Kyung Ah; Hong, Eungyoung; Kang, Jungoo; Chung, C. H.; Won, Jong-chul; Jeon, Eonju; Cho, Junghwan; Cho, Hochan; Kim, Sin Gon, et al.

ArticleIssue Date2025CitationDiabetes, Obesity and MetabolismPublisherJohn Wiley and Sons Inc
SCIESCOPUS
Efficacy and safety of dapagliflozin add-on to evogliptin plus metformin therapy in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled study

Jeong, In-Kyung; Choi, Kyung Mook; Han, Kyung Ah; Kim, Kyoung-Ah; Kim, In Joo; Han, Seung Jin; Lee, Won Young; Yoo, Soon Jib

ArticleIssue Date2024CitationDiabetes, Obesity and Metabolism, v.26, no.11, pp 5065 - 5077PublisherBlackwell Publishing Inc.
SCIESCOPUS
Long-term efficacy and safety of enavogliflozin in Korean people with type 2 diabetes: A 52-week extension of a Phase 3 randomized controlled trial

Kwak, Soo Heon; Han, Kyung Ah; Kim, Eun Sook; Choi, Sung Hee; Won, Jong Chul; Yu, Jae Myung; Oh, Seungjoon; Yoo, Hye Jin; Kim, Chong Hwa; Kim, Kyung-Soo, et al.

ArticleIssue Date2024CitationDiabetes, Obesity and Metabolism, v.26, no.10, pp 4203 - 4212PublisherBlackwell Publishing Inc.
SCIESCOPUS
Dual add-on therapy of gemigliptin and dapagliflozin in patients with type 2 diabetes inadequately controlled with metformin alone: The SOLUTION 2 study

Han, Kyung Ah; Hwang, You-Cheol; Moon, Shin Je; Cho, Ho Chan; Yoo, Hye Jin; Choi, Sung Hee; Chon, Suk; Kim, Kyoung-Ah; Kim, Tae Nyun; Kang, Jun Goo, et al.

ArticleIssue Date2024CitationDIABETES OBESITY & METABOLISM, v.26, no.9, pp 3743 - 3752PublisherWILEY
SCIESCOPUS
Antiobesity therapeutics with complementary dual-agonist activities at glucagon and glucagon-like peptide 1 receptors

Park, Bong Gyu; Kim, Gyeong Min; Lee, Hye-Jin; Ryu, Jae Ha; Kim, Dong-Hoon; Seong, Jae-Young; Kim, Soojeong; Park, Zee-Yong; Kim, Young-Joon; Lee, Jaemin, et al.

ArticleIssue Date2022CitationDiabetes, Obesity and Metabolism, v.24, no.1, pp 50 - 60PublisherBlackwell Publishing Inc.
SCIESCOPUS
Early combination versus initial metformin monotherapy in the management of newly diagnosed type 2 diabetes: An East Asian perspective

Ji, Linong; Chan, Juliana C. N.; Yu, Miao; Yoon, Kun Ho; Kim, Sin Gon; Choi, Sung Hee; Huang, Chien-Ning; Te Tu, Shih; Wang, Chih-Yuan; Paldanius, Paivi Maria, et al.

ArticleIssue Date2021CitationDiabetes, Obesity and Metabolism, v.23, no.1, pp 3 - 17PublisherBlackwell Publishing Inc.
SCIESCOPUS
Efficacy and safety of lobeglitazone versus sitagliptin as an add-on to metformin in patients with type 2 diabetes with two or more components of metabolic syndrome over 24 weeks

Kim, Sin Gon; Kim, Kyoung Jin; Yoon, Kun Ho; Chun, Sung Wan; Park, Kyong Soo; Choi, Kyung Mook; Lim, Soo; Mok, Ji-Oh; Lee, Hyoung Woo; Seo, Ji A., et al.

ArticleIssue Date2020CitationDiabetes, Obesity and Metabolism, v.22, no.10, pp 1869 - 1873PublisherBlackwell Publishing Inc.
SCIESCOPUS
Efficacy and safety of evogliptin treatment in patients with type 2 diabetes: A multicentre, active-controlled, randomized, double-blind study with open-label extension (the EVERGREEN study)

Kim, Gyuri; Lim, Soo; Kwon, Hyuk-Sang; Park, Ie B.; Ahn, Kyu J.; Park, Cheol-Young; Kwon, Su K.; Kim, Hye S.; Park, Seok W.; Kim, Sin G., et al.

ArticleIssue Date2020CitationDiabetes, Obesity and Metabolism, v.22, no.9, pp 1527 - 1536PublisherBlackwell Publishing Inc.
SCIESCOPUS
Comparison of pancreatic volume and fat amount linked with glucose homeostasis between healthy Caucasians and Koreans

Roh, Eun; Kim, Kyoung Min; Park, Kyeong Soo; Kim, Yoon Ji; Chun, Eun Ju; Choi, Sung Hee; Park, Kyong S.; Jang, Hak Chul; Lim, Soo

ArticleIssue Date2018CitationDiabetes, Obesity and Metabolism, v.20, no.11, pp 2642 - 2652PublisherBlackwell Publishing Inc.
SCIESCOPUS
Efficacy and safety of ipragliflozin as an add-on therapy to sitagliptin and metformin in Korean patients with inadequately controlled type 2 diabetes mellitus: A randomized controlled trial

Han, Kyung-Ah; Chon, Suk; Chung, Choon Hee; Lim, Soo; Lee, Kwan-Woo; Baik, SeiHyun; Jung, Chang Hee; Kim, Dong-Sun; Park, Kyong Soo; Yoon, Kun-Ho, et al.

ArticleIssue Date2018CitationDiabetes, Obesity and Metabolism, v.20, no.10, pp 2408 - 2415PublisherBlackwell Publishing Inc.
SCIESCOPUS
Long-term effects on glycaemic control and beta-cell preservation of early intensive treatment in patients with newly diagnosed type 2 diabetes: A multicentre randomized trial

Chon, Suk; Rhee, Sang Youl; Ahn, Kyu Jeung; Baik, Sei Hyun; Park, Yongsoo; Nam, Moon Suk; Lee, Kwan Woo; Yoo, Soon Jib; Koh, Gwanpyo; Lee, Dae Ho, et al.

ArticleIssue Date2018CitationDiabetes, Obesity and Metabolism, v.20, no.5, pp 1121 - 1130PublisherBlackwell Publishing Inc.
SCIESCOPUS
Comparative efficacy and safety of gemigliptin versus linagliptin in type 2 diabetes patients with renal impairment: A 40-week extension of the GUARD randomized study

Han, Sang Youb; Yoon, Sun Ae; Han, Byoung Geun; Kim, Sung Gyun; Jo, Young-Il; Jeong, Kyung Hwan; Oh, Kook-Hwan; Park, Hyeong Cheon; Park, Sun-Hee; Kang, Shin-Wook, et al.

ArticleIssue Date2018CitationDiabetes, Obesity and Metabolism, v.20, no.2, pp 292 - 300PublisherBlackwell Publishing Inc.
SCIESCOPUS
Efficacy and safety of evogliptin monotherapy in patients with type 2 diabetes and moderately elevated glycated haemoglobin levels after diet and exercise

Park, Juri; Park, Sung Woo; Yoon, Kun Ho; Kim, Sung Rae; Ahn, Kyu Jeung; Lee, Jae Hyuk; Mok, Ji Oh; Chung, Choon Hee; Han, Kyung Ah; Koh, Gwan Pyo, et al.

ArticleIssue Date2017CitationDiabetes, Obesity and Metabolism, v.19, no.12, pp 1681 - 1687PublisherBlackwell Publishing Inc.
SCIESCOPUS
Efficacy, safety and albuminuria-reducing effect of gemigliptin in Korean type 2 diabetes patients with moderate to severe renal impairment: A 12-week, double-blind randomized study (the GUARD Study)

Yoon, Sun A.; Han, Byoung G.; Kim, Sung G.; Han, Sang Y.; Jo, Young I.; Jeong, Kyung H.; Oh, Kook H.; Park, Hyeong C.; Park, Sun H.; Kang, Shin W., et al.

ArticleIssue Date2017CitationDiabetes, Obesity and Metabolism, v.19, no.4, pp 590 - 598PublisherBlackwell Publishing Inc.
1
CONTACT US

RSS_1.0 RSS_2.0 ATOM_1.0

73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265

COPYRIGHT 2020 KOREA UNIVERSITY MEDICAL LIBRARY ALL RIGHTS RESERVED.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어